Fennec Pharmaceuticals (FENC) EBT Margin (2020 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly EBT Margin came in at 34.22% in Q4 2025, down 1841.0% YoY from 1.97% in Q4 2024, and down 584.44% on a QoQ basis from 5.0% in Q3 2025.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) EBT Margin (2020 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 4 years of EBT Margin data on file, last reported at 34.22% in Q4 2025.
- Quarterly EBT Margin fell 1841.0% year-over-year to 34.22% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 21.63% (down 2253.0% YoY) and the FY2025 annual result came in at 10.51%, down 1485.0% from the prior year.
- EBT Margin declined to 34.22% in Q4 2025, from 5.0% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 50.86% in Q1 2024 to a low of 355.34% in Q1 2023.
- A 3-year average of 64.92% and a median of 29.94% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2024 — EBT Margin surged 40619 bps — and 2025, when it tumbled 6416 bps.
- Tracing FENC's EBT Margin over 3 years: stood at 26.89% in 2023, then jumped by 41 bps to 15.81% in 2024, then tumbled by 116 bps to 34.22% in 2025.
- The last three EBT Margin figures came in at 34.22% (Q4 2025), 5.0% (Q3 2025), and 32.69% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | 11.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.27% |
| Dec 31, 2025 | -19.12% |
| Sep 30, 2025 | -5.00% |
| Jun 30, 2025 | -32.66% |
| Mar 31, 2025 | -13.30% |
| Dec 31, 2024 | -18.94% |
| Sep 30, 2024 | -81.89% |
| Jun 30, 2024 | -75.92% |
| Mar 31, 2024 | 50.86% |
| Dec 31, 2023 | -26.89% |
| Sep 30, 2023 | -27.18% |
| Jun 30, 2023 | -161.68% |
| Mar 31, 2023 | -355.34% |
| Dec 31, 2020 | -1,666.50% |